Matches in SemOpenAlex for { <https://semopenalex.org/work/W2788794002> ?p ?o ?g. }
- W2788794002 endingPage "134" @default.
- W2788794002 startingPage "134" @default.
- W2788794002 abstract "Patients with metastatic castration-resistant prostate cancer (mCRPC) have poor outcomes. Docetaxel (DTX)-based therapy is a current standard treatment for patients with mCRPC. Approaches combining conventional chemotherapeutic agents and nanoparticles (NPs), particularly iron oxide NPs, may overcome the serious side effects and drug resistance, resulting in the establishment of new therapeutic strategies. We previously reported the combined effects of Fe3O4 nanoparticles (Fe3O4 NPs) with DTX on prostate cancer cells in vitro. In this study, we investigated the combined effects of Fe3O4 NPs and rapamycin or carboplatin on prostate cancer cells in vitro. Treatment of DU145 and PC-3 cells with Fe3O4 NPs increased intracellular reactive oxygen species (ROS) levels in a concentration-dependent manner. Treatment of both cell lines with 100 μg/mL Fe3O4 NPs for 72 h resulted in significant inhibition of cell viability with a different inhibitory effect. Combination treatments with 100 µg/mL Fe3O4 NPs and 10 µM carboplatin or 10 nM rapamycin in DU145 and PC-3 cells significantly decreased cell viability. Synergistic effects on apoptosis were observed in PC-3 cells treated with Fe3O4 NPs and rapamycin and in DU145 cells with Fe3O4 NPs and carboplatin. These results suggest the possibility of combination therapy with Fe3O4 NPs and various chemotherapeutic agents as a novel therapeutic strategy for patients with mCRPC." @default.
- W2788794002 created "2018-03-06" @default.
- W2788794002 creator A5000202860 @default.
- W2788794002 creator A5004563687 @default.
- W2788794002 creator A5014960402 @default.
- W2788794002 creator A5017271662 @default.
- W2788794002 creator A5018269639 @default.
- W2788794002 creator A5021633231 @default.
- W2788794002 creator A5040490999 @default.
- W2788794002 creator A5073366280 @default.
- W2788794002 date "2018-01-18" @default.
- W2788794002 modified "2023-09-26" @default.
- W2788794002 title "Combined Effects of Fe3O4 Nanoparticles and Chemotherapeutic Agents on Prostate Cancer Cells In Vitro" @default.
- W2788794002 cites W1525515409 @default.
- W2788794002 cites W1578932543 @default.
- W2788794002 cites W1949636578 @default.
- W2788794002 cites W1967231442 @default.
- W2788794002 cites W1973206036 @default.
- W2788794002 cites W1973628309 @default.
- W2788794002 cites W1987702513 @default.
- W2788794002 cites W2004859816 @default.
- W2788794002 cites W2008473350 @default.
- W2788794002 cites W2014223394 @default.
- W2788794002 cites W2024504871 @default.
- W2788794002 cites W2032431432 @default.
- W2788794002 cites W2045080998 @default.
- W2788794002 cites W2055616071 @default.
- W2788794002 cites W2067242125 @default.
- W2788794002 cites W2069467605 @default.
- W2788794002 cites W2073126015 @default.
- W2788794002 cites W2075741216 @default.
- W2788794002 cites W2089146874 @default.
- W2788794002 cites W2094622646 @default.
- W2788794002 cites W2107275684 @default.
- W2788794002 cites W2123077206 @default.
- W2788794002 cites W2123799923 @default.
- W2788794002 cites W2136147886 @default.
- W2788794002 cites W2145706118 @default.
- W2788794002 cites W2155432159 @default.
- W2788794002 cites W2159411213 @default.
- W2788794002 cites W2159497139 @default.
- W2788794002 cites W2168561406 @default.
- W2788794002 cites W2190667064 @default.
- W2788794002 cites W2235523093 @default.
- W2788794002 cites W2334063602 @default.
- W2788794002 cites W2417722289 @default.
- W2788794002 cites W2433244250 @default.
- W2788794002 doi "https://doi.org/10.3390/app8010134" @default.
- W2788794002 hasPublicationYear "2018" @default.
- W2788794002 type Work @default.
- W2788794002 sameAs 2788794002 @default.
- W2788794002 citedByCount "14" @default.
- W2788794002 countsByYear W27887940022019 @default.
- W2788794002 countsByYear W27887940022020 @default.
- W2788794002 countsByYear W27887940022021 @default.
- W2788794002 countsByYear W27887940022022 @default.
- W2788794002 countsByYear W27887940022023 @default.
- W2788794002 crossrefType "journal-article" @default.
- W2788794002 hasAuthorship W2788794002A5000202860 @default.
- W2788794002 hasAuthorship W2788794002A5004563687 @default.
- W2788794002 hasAuthorship W2788794002A5014960402 @default.
- W2788794002 hasAuthorship W2788794002A5017271662 @default.
- W2788794002 hasAuthorship W2788794002A5018269639 @default.
- W2788794002 hasAuthorship W2788794002A5021633231 @default.
- W2788794002 hasAuthorship W2788794002A5040490999 @default.
- W2788794002 hasAuthorship W2788794002A5073366280 @default.
- W2788794002 hasBestOaLocation W27887940021 @default.
- W2788794002 hasConcept C121608353 @default.
- W2788794002 hasConcept C126322002 @default.
- W2788794002 hasConcept C185592680 @default.
- W2788794002 hasConcept C190283241 @default.
- W2788794002 hasConcept C202751555 @default.
- W2788794002 hasConcept C2776438761 @default.
- W2788794002 hasConcept C2776694085 @default.
- W2788794002 hasConcept C2778239845 @default.
- W2788794002 hasConcept C2779723316 @default.
- W2788794002 hasConcept C2780192828 @default.
- W2788794002 hasConcept C2781190966 @default.
- W2788794002 hasConcept C2781451048 @default.
- W2788794002 hasConcept C502942594 @default.
- W2788794002 hasConcept C53227056 @default.
- W2788794002 hasConcept C55493867 @default.
- W2788794002 hasConcept C71924100 @default.
- W2788794002 hasConcept C96232424 @default.
- W2788794002 hasConcept C98274493 @default.
- W2788794002 hasConceptScore W2788794002C121608353 @default.
- W2788794002 hasConceptScore W2788794002C126322002 @default.
- W2788794002 hasConceptScore W2788794002C185592680 @default.
- W2788794002 hasConceptScore W2788794002C190283241 @default.
- W2788794002 hasConceptScore W2788794002C202751555 @default.
- W2788794002 hasConceptScore W2788794002C2776438761 @default.
- W2788794002 hasConceptScore W2788794002C2776694085 @default.
- W2788794002 hasConceptScore W2788794002C2778239845 @default.
- W2788794002 hasConceptScore W2788794002C2779723316 @default.
- W2788794002 hasConceptScore W2788794002C2780192828 @default.
- W2788794002 hasConceptScore W2788794002C2781190966 @default.
- W2788794002 hasConceptScore W2788794002C2781451048 @default.
- W2788794002 hasConceptScore W2788794002C502942594 @default.